期刊文献+

利心冲剂对阿霉素所致慢性心力衰竭大鼠TIMP-1、TGF-β的影响 被引量:4

Effects of "Lixin Granule" on TIMP-1 and TGF-β in Rats of Chronic Heart Failure Following Adriamycin
原文传递
导出
摘要 目的研究利心冲剂对心衰大鼠基质金属蛋白酶组织抑制因子(TIMP-1)和转化生长因子β(TGF-β)的影响。方法50只Wistar大鼠,随机取10只为正常组,余40只腹腔注射阿霉素(ADR)4mg/kg,每5天1次,共3次,复制大鼠慢性心力衰竭模型。造模成功后分为模型组、阳性药物组、利心冲剂低剂量组、利心冲剂高剂量组。阳性药物组、利心冲剂低剂量组、利心冲剂高剂量组大鼠于造模成功后次日灌胃给药,连续给药21d后,采用Real time PCR检测B型利钠肽(BNP),亲和组织化学技术三步法(SABC法)免疫组织化学检测TIMP-1、TGF-β的表达。结果与模型组比较,利心冲剂低剂量组、高剂量组治疗后胶原沉积明显减少,以高剂量组最为明显;BNP、TGF-β表达明显下降(P<0.01),以高剂量组为显著;TIMP-1的表达明显增加。结论利心冲剂调控TIMP-1、TGF-β信号通路,抑制胶原沉积,改善心功能。 Objective To study the effects of "Lixin Granule" on tissue inhibitor of metalloproteinase-1 (TIMP-1) and transformation growth factor β(TGF-β) in rats of chronic heart failure due to Adriamycin. Methods Fifty rats were randomized into normal group, model group, control grnup, luw-duse " Lixin Granule" group and high-Jose "Lixin Granule" group. Rat model was duplicated by intraabdominal injection of Adrlamycin at 5 mg/kg, once every five days for total three times. Brain natriuretic peptide(BNP) was detected by Real Time PCR, TIMP-1 and TGF-β expressions by SABC immuno-histochemical method. Results Compared with model group, collagen sedimentation was obviously reduced in "Lixin Granule" groups, especially in high-dose "Lixin Granule" group; BNP and TGF-β expressions were evidently reduced(P 〈0.01 ), especially in high-dose "Lixin Granule" group; TIMP-1 expression was increased. Conclusion "Lixin Granule" can regulate TIMP-1 and TGF-β signal pathway and suppress collagen sedimentation to improve the heart functions.
出处 《上海中医药杂志》 2009年第10期62-64,共3页 Shanghai Journal of Traditional Chinese Medicine
基金 江苏省中医药局中医药科技专项资助项目(HZ07072)
关键词 利心冲剂 心衰大鼠模型 BNP TIMP-1 TGF-Β "Lixin Granule" heart failure rat model Brain natriuretic peptide(BNP) tissue inhibitor of metalloproleinase-1 ( TIMP-1) transformation growth factor β( TGF-β )
  • 相关文献

参考文献9

二级参考文献61

  • 1杨永健,朱文玲,张鑫,周兴文,祝之明.PTEN/磷脂酰肌醇3激酶通路在心力衰竭患者心肌重构中的信号传导作用[J].中华医学杂志,2005,85(17):1201-1204. 被引量:18
  • 2[1]Bruckner-Tuderman L, Bruckner P. J Mol Med,1998; 76(3): 226~237
  • 3[2]Poole-Wilson PA. J Am Coll Cardiol, 1993; 22(4 suppl A): A22~A29
  • 4[3]Weber KT, Anversa P, Armstrong PW, et al.J Am Coll Cardiol, 1992; 20(2):3~16
  • 5[4]Pfeffer MA, Braunwald E. Circulation, 1990;81(4): 1161~1172
  • 6[5]Cohn JN. Clin Cardiol, 1995; 18(9 suppl Ⅳ):Ⅳ4~Ⅳ12
  • 7[6]Kitson RP, Appasamy PM, Nannmark U, et al. J Immunol, 1998; 160(9): 4248~4253
  • 8[7]Thomas CV, Coker ML, Zellner JL, et al. Circulation, 1998; 97(17): 1708~1715
  • 9[8]Weber KT, Pick R, Janicki JS, et al. Am Heart J, 1988; 116(6 Pt 1): 1641~1646
  • 10[9]Weber KT, Sun Y, Tyagi S, et al. J Mol Cell Cardiol, 1994; 26(37): 279~292

共引文献90

同被引文献74

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部